ESSA Pharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ESSA Pharma Inc
TickerEPIX
CIK #0001633932
CUSIP29668H708
SectorLife Sciences - Pharmaceutical Preparations
AddressSuite 720 999 West Broadway, Vancouver, BC V5Z 1K5
Source [EDGAR]
CIK Filing 2011 - 2025
[0001633932] 10-K
[0001633932] 10-Q
[0001633932] 3
[0001633932] 4
[0001633932] 6-K
[0001633932] 8-K
[0001633932] D
[0001633932] SC 13D
[0001633932] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Tang Capital Management LLC ESSA Pharma Inc [2025-07-30] 0.0
BML Investment Partners LP ESSA Pharma Inc [2025-04-24] 0.0
Soleus Capital Master Fund LP ESSA Pharma Inc [2025-04-15] 0.0
Biotechnology Value Fund L P ESSA Pharma Inc [2025-04-09] 0.0
Tang Capital Management LLC ESSA Pharma Inc [2024-11-08] 11.0
BML Investment Partners LP ESSA Pharma Inc [2024-11-07] 0.4
RTW Investments LP ESSA Pharma Inc [2024-02-14] 5.2
Morgan Stanley ESSA Pharma Inc [2024-02-08] 9.5
PFM Health Sciences LP ESSA Pharma Inc [2022-11-10] 8.7
Avidity Partners Management LP ESSA Pharma Inc [2022-10-27] 8.5
Janus Henderson Group PLC ESSA Pharma Inc [2022-02-11] 7.7
RTW Investments LP ESSA Pharma Inc [2021-07-02] 7.49
BB Biotech AG ESSA Pharma Inc [2021-05-05] 5.1
Driehaus Capital Management LLC ESSA Pharma Inc [2021-02-16] 5.03
Driehaus Capital Management LLC ESSA Pharma Inc [2021-02-16] 5.03
Vivo Capital IX LLC ESSA Pharma Inc [2020-11-06] 1.0
Pfizer Inc ESSA Pharma Inc [2020-08-06] 6.0
OrbiMed Advisors LLC ESSA Pharma Inc [2019-11-12] 7.1
Eventide Asset Management LLC ESSA Pharma Inc [2019-08-30] 0.68
Soleus Capital LLC ESSA Pharma Inc [2019-08-28] 0.99
Eventide Asset Management LLC ESSA Pharma Inc [2019-05-23] 19.2
Omega Fund IV LP ESSA Pharma Inc [2019-02-13] 17.2
Biotechnology Value Fund L P ESSA Pharma Inc [2018-01-16] 4.7
Eventide Asset Management LLC ESSA Pharma Inc [2017-02-13] 0.3
Marxe Austin W & Greenhouse David M ESSA Pharma Inc [2017-02-10] 9.99
Marxe Austin W & Greenhouse David M ESSA Pharma Inc [2017-02-10] 9.99
Clarus Lifesciences III LP ESSA Pharma Inc [2016-01-26] 13.8
Andersen Raymond John ESSA Pharma Inc [2016-01-25] 12.93
Sadar Marianne D ESSA Pharma Inc [2016-01-25] 12.94
Rieder Robert William ESSA Pharma Inc [2016-01-25] 0.82
Glickman Richard M ESSA Pharma Inc [2016-01-25] 2.9
Omega Fund IV LP ESSA Pharma Inc [2016-01-22] 9.28
Flynn James E ESSA Pharma Inc [2015-07-20] 4.2
Form 3/4/5 Filer 2011 - 2025
BVF II GP LLC
BVF Partners OS Ltd.
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
Lampert Mark N
BVF I GP LLC
ESSA Pharma Inc.
BVF Partners L P/IL
Biotechnology Value Trading Fund OS LP
BVF Inc/IL
BVF GP Holdings LLC
Biotech Growth N V
BB Biotech AG
Virsik Peter
Glickman Richard M
Cesano Alessandra
Parkinson David Ross
Wood David S.
Berger Franklin M
Kantoff Philip W.
Martin John Alexander
Merendino Lauren
Requadt Scott
Sollis Gary
Thorell Marella
Zweifach Sanford S
Brettman Ari David
Schwarzman Stephen A
Blackstone Clarus III L.L.C.
Blackstone Holdings II L.P.
Clarus Lifesciences III, L.P.
Blackstone Holdings I/II GP L.L.C.
Blackstone Inc.
Blackstone Group Management L.L.C.
Clarus Ventures III GP, L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
BVF Inc/IL [2025-06-30] DFND 0 8,748,629
Tang Capital Management LLC [2025-06-30] OTR 0 4,300,000
BML Capital Management LLC [2025-06-30] SOLE 0 4,221,546
Morgan Stanley [2025-06-30] DFND 4,174,170 4,209,670
Soleus Capital Management LP [2025-06-30] SOLE 2,262,026 2,262,026
Opaleye Management Inc [2025-06-30] SOLE 2,209,998 2,209,998
Pfizer Inc [2025-06-30] SOLE 1,675,000 1,675,000
Bank of America Corp /DE/ [2025-06-30] DFND 0 627,930
Aldebaran Capital LLC [2025-06-30] SOLE 578,939 578,939
Susquehanna International Group LLP [2025-06-30] OTR 0 405,800
DLD Asset Management LP [2025-06-30] SOLE 314,968 314,968
BNP Paribas Financial Markets [2025-06-30] DFND 0 271,195
Two Sigma Advisers LP [2025-06-30] SOLE 250,900 260,800
Two Sigma Investments LP [2025-06-30] SOLE 222,327 222,327
LMR Partners LLP [2025-06-30] SOLE 200,000 200,000
Jane Street Group LLC [2025-06-30] DFND 152,107 192,707
JPMorgan Chase & Co [2025-06-30] DFND 189,094 189,094
Rangeley Capital LLC [2025-06-30] SOLE 170,000 170,000
Citadel Advisors LLC [2025-06-30] DFND 145,639 145,639
Group One Trading LLC [2025-06-30] SOLE 83,823 83,823
Magnus Financial Group LLC [2025-06-30] SOLE 0 55,206
Adar1 Capital Management LLC [2025-06-30] SOLE 50,000 50,000
American Century Companies Inc [2025-06-30] DFND 46,373 46,373
XTX Topco Ltd [2025-06-30] DFND 42,173 42,173
Lepercq de Neuflize Asset Management LLC [2025-06-30] SOLE 33,700 33,700
Shay Capital LLC [2025-06-30] SOLE 24,348 24,348
Geode Capital Management LLC [2025-06-30] DFND 23,840 23,840
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 14,343 14,343
UBS Group AG [2025-06-30] DFND 12,021 12,021
BlackRock, Inc. [2025-06-30] SOLE 7,074 7,074
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com